Genetics

This scientific blog post examines recent evidence showing that the genetic variants associated with multiple sclerosis susceptibility are largely distinct from those that influence long-term disease severity, neuroimaging changes, and treatment response. Drawing on the reviewed article, it explains how MS risk genetics predominantly implicates immune pathways, whereas severity genetics appears to be more closely linked to central nervous system biology, neurodegeneration, and tissue resilience. The post highlights the implications of this distinction for prognosis, biomarker development, pharmacogenetics, and the future of precision medicine in multiple sclerosis.